Abstract
The novel coronavirus was first identified toward the end of 2019 ,designated as coronavirus disease 2019(COVID-19).The morbidity and mortality from COVID are particularly high among patients with underlying health conditions and chronic diseases.Kidney-transplant recipients appear to be at particularly high risk for critical Covid illness due to chronic immunosuppression and coexisting conditionsThe outcome of covid 19 infection in transplant patients is unclear. Hence we have retrospectively analysed covid positive transplant recipients to assess the clinical profile,Outcomes and Management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
